Cargando…

DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial

PURPOSE: Trials aiming to lower homocysteine by B-vitamin supplementation have reported mixed results on slowing cognitive decline. We investigated if efficacy of B-vitamin supplementation is affected by baseline plasma omega-3 fatty acid levels. METHODS: This post-hoc analysis of the B-proof trial...

Descripción completa

Detalles Bibliográficos
Autores principales: van Soest, Annick P. M., van de Rest, Ondine, Witkamp, Renger F., Cederholm, Tommy, de Groot, Lisette C. P. G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464144/
https://www.ncbi.nlm.nih.gov/pubmed/35704085
http://dx.doi.org/10.1007/s00394-022-02924-w
_version_ 1784787517899276288
author van Soest, Annick P. M.
van de Rest, Ondine
Witkamp, Renger F.
Cederholm, Tommy
de Groot, Lisette C. P. G. M.
author_facet van Soest, Annick P. M.
van de Rest, Ondine
Witkamp, Renger F.
Cederholm, Tommy
de Groot, Lisette C. P. G. M.
author_sort van Soest, Annick P. M.
collection PubMed
description PURPOSE: Trials aiming to lower homocysteine by B-vitamin supplementation have reported mixed results on slowing cognitive decline. We investigated if efficacy of B-vitamin supplementation is affected by baseline plasma omega-3 fatty acid levels. METHODS: This post-hoc analysis of the B-proof trial included 191 adults aged 65 years or older with baseline plasma total homocysteine ≥ 12 μmol/L, randomly assigned to 400 µg folic acid and 500 µg vitamin B12 or placebo daily for 2 years. Global and domain-specific cognitive functioning were assessed at baseline and after 2 years. The effect of B-vitamin supplementation was analyzed according to tertiles of baseline plasma omega-3 fatty acids concentrations combined, and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) individually using multiple linear regression analyses. RESULTS: The mean ± SD age of the participants was 71.6 ± 5.9 years and median [IQR] Mini-Mental State Examination was 29 [28–30]. The treatment effect of B-vitamins on global cognition was larger in participants in the high compared to the middle DHA tertile (difference in z-score, mean ± SE 0.22 ± 0.10, p = 0.03). There was no significant interaction between B-vitamin supplementation and combined omega-3 fatty acid (p = 0.49) and EPA (p = 0.99) tertiles. Similarly, the efficacy of B-vitamin treatment on domain-specific cognitive functioning did not link to omega-3 fatty acid, DHA, or EPA plasma levels. CONCLUSION: This post-hoc analysis indicated that efficacy of B-vitamin supplementation in slowing cognitive decline relates to DHA status, with individuals with higher plasma DHA levels benefitting more from vitamin B12 and folic acid use. The results support earlier observations that positive effects of B-vitamins in cognitive ageing may be subgroup-specific. Trial registration: Registered at clinicaltrials.gov (NCT00696514) on June 12, 2008. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00394-022-02924-w.
format Online
Article
Text
id pubmed-9464144
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94641442022-09-12 DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial van Soest, Annick P. M. van de Rest, Ondine Witkamp, Renger F. Cederholm, Tommy de Groot, Lisette C. P. G. M. Eur J Nutr Original Contribution PURPOSE: Trials aiming to lower homocysteine by B-vitamin supplementation have reported mixed results on slowing cognitive decline. We investigated if efficacy of B-vitamin supplementation is affected by baseline plasma omega-3 fatty acid levels. METHODS: This post-hoc analysis of the B-proof trial included 191 adults aged 65 years or older with baseline plasma total homocysteine ≥ 12 μmol/L, randomly assigned to 400 µg folic acid and 500 µg vitamin B12 or placebo daily for 2 years. Global and domain-specific cognitive functioning were assessed at baseline and after 2 years. The effect of B-vitamin supplementation was analyzed according to tertiles of baseline plasma omega-3 fatty acids concentrations combined, and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) individually using multiple linear regression analyses. RESULTS: The mean ± SD age of the participants was 71.6 ± 5.9 years and median [IQR] Mini-Mental State Examination was 29 [28–30]. The treatment effect of B-vitamins on global cognition was larger in participants in the high compared to the middle DHA tertile (difference in z-score, mean ± SE 0.22 ± 0.10, p = 0.03). There was no significant interaction between B-vitamin supplementation and combined omega-3 fatty acid (p = 0.49) and EPA (p = 0.99) tertiles. Similarly, the efficacy of B-vitamin treatment on domain-specific cognitive functioning did not link to omega-3 fatty acid, DHA, or EPA plasma levels. CONCLUSION: This post-hoc analysis indicated that efficacy of B-vitamin supplementation in slowing cognitive decline relates to DHA status, with individuals with higher plasma DHA levels benefitting more from vitamin B12 and folic acid use. The results support earlier observations that positive effects of B-vitamins in cognitive ageing may be subgroup-specific. Trial registration: Registered at clinicaltrials.gov (NCT00696514) on June 12, 2008. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00394-022-02924-w. Springer Berlin Heidelberg 2022-06-15 2022 /pmc/articles/PMC9464144/ /pubmed/35704085 http://dx.doi.org/10.1007/s00394-022-02924-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Contribution
van Soest, Annick P. M.
van de Rest, Ondine
Witkamp, Renger F.
Cederholm, Tommy
de Groot, Lisette C. P. G. M.
DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
title DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
title_full DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
title_fullStr DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
title_full_unstemmed DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
title_short DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
title_sort dha status influences effects of b-vitamin supplementation on cognitive ageing: a post-hoc analysis of the b-proof trial
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464144/
https://www.ncbi.nlm.nih.gov/pubmed/35704085
http://dx.doi.org/10.1007/s00394-022-02924-w
work_keys_str_mv AT vansoestannickpm dhastatusinfluenceseffectsofbvitaminsupplementationoncognitiveageingaposthocanalysisofthebprooftrial
AT vanderestondine dhastatusinfluenceseffectsofbvitaminsupplementationoncognitiveageingaposthocanalysisofthebprooftrial
AT witkamprengerf dhastatusinfluenceseffectsofbvitaminsupplementationoncognitiveageingaposthocanalysisofthebprooftrial
AT cederholmtommy dhastatusinfluenceseffectsofbvitaminsupplementationoncognitiveageingaposthocanalysisofthebprooftrial
AT degrootlisettecpgm dhastatusinfluenceseffectsofbvitaminsupplementationoncognitiveageingaposthocanalysisofthebprooftrial